Valsalva maneuver using a Handmade Device in Supraventricular Tachycardia Reversion; a Quasi Experimental Study
学术急诊医学档案,
卷 5 编号 1 (2017),
1 一月 2017
,
第 e81 页
https://doi.org/10.22037/aaem.v5i1.206
摘要
Introduction: The use of vagal nerve stimulation is identified as a proper treatment option in patients with stable supraventricular tachycardia (SVT). This study aimed to assess the success of Valsalva maneuver via a handmade device in reversion of SVT. Methods: In this quasi experimental study, using a handmade device, vagus nerve stimulation was performed for SVT patients presenting to emergency department or cardiac intervention unit and the success rate and its related factors were assessed. Results: 100 patients with the mean age of 53.05 ± 13.70 years were studied (67% female). 12 (12%) cases were unable to do the maneuver. Out of the 88 (88.0%) patients who could perform the maneuver, 75 (85.2%) cases were unsuccessful. Dysrhythmia was controlled in 6 (6.8%) cases on the first attempt and in 7 (8.0%) cases on the second one (14.8% total success rate). 12 of the 13 cases (92.3%) with successful maneuver had history of SVT (p = 0.031). There was not any significant association between success rate and sex (p = 0.084), age (p = 0.744), or other medical histories (p ≥ 0.05). Conclusion: Based on the results of the present study, the success rate of Valsalva maneuver with the mentioned handmade device was calculated to be 14.8%. The only independent related factor of successful reversion was SVT history.- Vagus nerve stimulation
- Valsalva maneuver
- tachycardia
- supraventricular
- arrhythmias
- cardiac
- emergency service
- hospital
##submission.howToCite##
参考
Orejarena LA, Vidaillet H, DeStefano F, Nordstrom DL, Vierkant RA, Smith PN, et al. Paroxysmal supraventricular tachycardia in the general population. Journal of the American College of Cardiology. 1998;31(1):150-7.
Bibas L, Levi M, Essebag V. Diagnosis and management of supraventricular tachycardias. CMAJ: Canadian Medical Association journal= journal de l'Association medicale canadienne. 2016;188(17-18):E466.
Al-Zaiti SS, Magdic KS. Paroxysmal Supraventricular Tachycardia. Critical Care Nursing Clinics. 2016;28(3):309-16.
Rujic D, Sundbøll J, Tofig B, Nielsen J, Pareek M. Initial evaluation and management of paroxysmal supraventricular tachycardia. Ugeskrift for laeger. 2016;178(3).
Sawan N, Eitel C, Thiele H. Ablation supraventrikulärer Tachykardien. Herzschrittmachertherapie+ Elektrophysiologie. 2016;27(2):143-50.
Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia. Journal of the American College of Cardiology. 2016;67(13):e27-e115.
Chun HM, Sung RJ. Supraventricular tachyarrhythmias: Pharrnacologic versus nonpharrnacologic approaches. Medical Clinics of North America. 1995;79(5):1121-34.
Scheinman M. Supraventricular tachyarrhythmias: drug therapy versus catheter ablation. Clinical cardiology. 1994;17(S2).
Waldo AL. An approach to therapy of supraventricular tachyarrhythmias: an algorithm versus individualized therapy. Clinical cardiology. 1994;17(S2).
Cheng C, Sanders G, Hlatky M, Heidenreich P, McDonald K, Lee B, et al. Cost-Effectiveness of Radiofrequency Ablation for Supraventricular Tachycardia. 2000.
Link MS. Evaluation and initial treatment of supraventricular tachycardia. New England Journal of Medicine. 2012;367(15):1438-48.
Holdgate A, Foo A. Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults. Cochrane Database Syst Rev. 2006;4.
Delaney B, Loy J, Kelly A-M. The relative efficacy of adenosine versus verapamil for the treatment of stable paroxysmal supraventricular tachycardia in adults: a meta-analysis. European Journal of Emergency Medicine. 2011;18(3):148-52.
Whinnett ZI, Sohaib SA, Davies DW. Diagnosis and management of supraventricular tachycardia. BMJ. 2012;345:e7769.
Waxman MB, Wald RW, Sharma AD, Huerta F, Cameron DA. Vagal techniques for termination of paroxysmal supraventricular tachycardia. The American journal of cardiology. 1980;46(4):655-64.
Wen Z-C, Chen S-A, Tai C-T, Chiang C-E, Chiou C-W, Chang M-S. Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia. Circulation. 1998;98(24):2716-23.
Lim S, Anantharaman V, Teo W, Goh P, Tan A. Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Annals of emergency medicine. 1998;31(1):30-5.
Smith G. Management of supraventricular tachycardia using the Valsalva manoeuvre: a historical review and summary of published evidence. European Journal of Emergency Medicine. 2012;19(6):346-52.
Ferguson JD, DiMarco JP. Contemporary management of paroxysmal supraventricular tachycardia. Circulation. 2003;107(8):1096-9.
Sohinki D, Obel OA. Current trends in supraventricular tachycardia management. The Ochsner Journal. 2014;14(4):586-95.
Taylor DM, Auble TF, Yealy DM. First-line management of paroxysmal supraventricular tachycardia. The American journal of emergency medicine. 1999;17(2):214-6.
Looga R. The Valsalva manoeuvre—cardiovascular effects and performance technique: a critical review. Respiratory physiology & neurobiology. 2005;147(1):39-49.
Waxman MB, Wald RW, Finley JP, Bonet JF, Downar E, Sharma AD. Valsalva termination of ventricular tachycardia. Circulation. 1980;62(4):843-51.
Taylor DM, Wong LF. Incorrect instruction in the use of the Valsalva manoeuvre for paroxysmal supraâ€ventricular tachycardia is common. Emergency Medicine Australasia. 2004;16(4):284-7.
- 摘要 ##plugins.themes.ojsPlusA.frontend.article.viewed##: 436 ##plugins.themes.ojsPlusA.frontend.article.times##
- PDF (English) ##plugins.themes.ojsPlusA.frontend.article.downloaded##: 167 ##plugins.themes.ojsPlusA.frontend.article.times##
##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##
##plugins.block.makeSubmission.linkLabel##
SJR
COPE
